Alfacell Corporation (Bloomfield, N...
Alfacell Corporation (Bloomfield, NJ) has published ends of a Phase 2 trial of Onconase (ranpirnase), an anticancer physic in patients with inoperable malignant mesothelioma, an asbestos-related cancer. The conclusions were published in the 1 January 2002 issue of the Journal of Clinical Oncology One-and
|